Profile data is unavailable for this security.
About the company
ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
- Revenue in USD (TTM)2.30m
- Net income in USD-27.05m
- Incorporated2021
- Employees76.00
- LocationASP Isotopes Inc1101 Pennsylvania Avenue Nw, Suite 300WASHINGTON 20004United StatesUSA
- Phone+1 (202) 756-2245
- Fax+1 (302) 636-5454
- Websitehttps://aspisotopes.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OptiNose Inc | 75.06m | -40.91m | 128.16m | 132.00 | -- | -- | -- | 1.71 | -0.3479 | -0.3479 | 0.6195 | -0.2863 | 0.6309 | 0.7909 | 3.50 | 568,621.20 | -34.39 | -48.25 | -199.84 | -98.95 | 89.92 | 86.96 | -54.50 | -131.66 | 3.59 | -0.8537 | 1.52 | -- | -6.93 | 58.64 | 52.58 | -- | -27.96 | -- |
Elutia Inc | 24.99m | -70.10m | 131.47m | 54.00 | -- | -- | -- | 5.26 | -3.05 | -2.86 | 1.12 | -2.28 | 0.5303 | 2.32 | 5.08 | 462,722.20 | -148.77 | -42.93 | -1,212.93 | -79.34 | 42.46 | 43.32 | -280.53 | -64.16 | 0.6842 | -0.6561 | -- | -- | -49.69 | -8.71 | -25.39 | -- | 12.74 | -- |
Global Pharmatech Inc. | 3.18m | -2.24m | 138.32m | 217.00 | -- | 1.02 | -- | 43.51 | -0.0964 | -0.0964 | 0.1367 | 0.3428 | 0.2292 | 1.59 | 3.57 | 14,649.77 | -16.44 | -- | -22.55 | -- | 46.21 | -- | -71.75 | -- | 1.62 | -9.87 | 0.2223 | -- | 32.43 | -- | -142.03 | -- | -- | -- |
Hongchang International Co Ltd | 4.65m | -292.22k | 140.08m | 8.00 | -- | 3.57 | -- | 30.13 | -0.0006 | -0.0006 | 0.0093 | 0.0757 | 0.1647 | 5.02 | 8.74 | -- | -0.8827 | -7.98 | -0.9331 | -10.94 | 3.92 | 11.47 | -5.36 | -64.88 | 3.77 | -- | 0.2642 | -- | 3,289.22 | -- | -42.63 | -- | -- | -- |
Eton Pharmaceuticals Inc | 31.38m | -6.69m | 152.69m | 30.00 | -- | 11.30 | -- | 4.87 | -0.2596 | -0.2596 | 1.22 | 0.5229 | 1.00 | 8.82 | 7.89 | 1,046,033.00 | -21.31 | -46.22 | -38.27 | -58.20 | 59.48 | 72.16 | -21.31 | -76.86 | 1.28 | -- | 0.2571 | -- | 48.90 | -- | 89.62 | -- | 26.85 | -- |
Biostem Technologies Inc | 131.44m | 7.87m | 158.96m | 67.00 | 29.17 | 8.78 | 19.66 | 1.21 | 0.3346 | 0.3346 | 7.31 | 1.11 | 2.80 | 7.41 | 3.35 | -- | 16.78 | -- | 107.11 | -- | 94.73 | -- | 5.98 | -- | 1.20 | 15.52 | 0.2012 | -- | -- | -- | -- | -- | -- | -- |
Lifecore Biomedical Inc | 128.26m | 9.33m | 160.67m | 524.00 | 35.09 | 14.05 | 8.83 | 1.25 | 0.1482 | 0.2318 | 3.83 | 1.76 | 0.5055 | 2.14 | 4.26 | 244,774.80 | 3.68 | -5.91 | 4.35 | -8.33 | 32.63 | 31.01 | 7.27 | -19.16 | 1.06 | 0.2373 | 0.6923 | -- | 24.20 | -25.46 | 114.53 | 34.47 | -16.72 | -- |
ASP Isotopes Inc | 2.30m | -27.05m | 177.39m | 76.00 | -- | 12.59 | -- | 77.27 | -0.628 | -0.628 | 0.0549 | 0.2112 | 0.068 | -- | -- | 30,206.32 | -71.81 | -- | -89.44 | -- | 36.54 | -- | -1,055.85 | -- | -- | -8.11 | 0.6748 | -- | -- | -- | -229.34 | -- | -- | -- |
Telomir Pharmaceuticals Inc | 0.00 | -18.74m | 177.66m | 1.00 | -- | 113.33 | -- | -- | -0.6855 | -0.6855 | 0.00 | 0.0529 | 0.00 | -- | -- | 0.00 | -467.16 | -- | -686.91 | -- | -- | -- | -- | -- | -- | -0.9299 | 0.00 | -- | -- | -- | -1,430.39 | -- | -- | -- |
Greenwich Lifesciences Inc | 0.00 | -10.22m | 186.26m | 3.00 | -- | 31.52 | -- | -- | -0.7942 | -0.7942 | 0.00 | 0.4496 | 0.00 | -- | -- | 0.00 | -112.41 | -36.43 | -123.67 | -38.31 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -13.63 | -- | -- | -- |
Mediwound Ltd | 20.14m | -19.97m | 189.52m | 100.00 | -- | 9.13 | -- | 9.41 | -2.16 | -2.16 | 2.18 | 1.92 | 0.3311 | 5.53 | 6.55 | 201,410.00 | -32.83 | -24.48 | -49.28 | -32.92 | 13.25 | 43.27 | -99.17 | -38.43 | 1.51 | -3.26 | 0.2623 | -- | -29.48 | 40.60 | 65.73 | -- | 64.66 | -- |
Scilex Holding Co | 50.83m | -171.53m | 193.71m | 113.00 | -- | -- | -- | 3.81 | -1.40 | -1.40 | 0.4425 | -1.77 | 0.4401 | 5.22 | 1.55 | 484,123.80 | -102.93 | -- | -- | -- | 68.24 | -- | -233.88 | -- | 0.1853 | -3.72 | -- | -- | 22.90 | -- | -614.67 | -- | -- | -- |
Amylyx Pharmaceuticals Inc | 298.76m | -165.87m | 196.08m | 384.00 | -- | 0.7503 | -- | 0.6563 | -2.45 | -2.45 | 4.34 | 3.84 | 0.7605 | 3.69 | 15.91 | 778,026.10 | -42.22 | -- | -50.91 | -- | 84.64 | -- | -55.52 | -- | 4.66 | -- | 0.00 | -- | 1,612.94 | -- | 124.84 | -- | -- | -- |
Procaps Group SA | 414.10m | 52.20m | 204.21m | 5.50k | 3.47 | 5.18 | 2.93 | 0.4932 | 0.5209 | 0.5209 | 4.16 | 0.3491 | 0.854 | 1.87 | 3.38 | 75,290.18 | 10.77 | -- | 19.01 | -- | 55.04 | -- | 12.61 | -- | 0.9861 | -- | 0.8829 | -- | 0.0434 | -- | 142.18 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
BlackRock Fund Advisorsas of 30 Jun 2024 | 1.94m | 2.91% |
The Vanguard Group, Inc.as of 30 Jun 2024 | 1.68m | 2.52% |
Geode Capital Management LLCas of 30 Jun 2024 | 783.59k | 1.18% |
SSgA Funds Management, Inc.as of 30 Jun 2024 | 757.09k | 1.14% |
Marshall Wace LLPas of 30 Jun 2024 | 545.07k | 0.82% |
GSA Capital Partners LLPas of 30 Jun 2024 | 393.27k | 0.59% |
Philadelphia Financial Management of San Francisco LLCas of 30 Jun 2024 | 383.97k | 0.58% |
Rovida Advisors, Inc.as of 30 Jun 2024 | 350.00k | 0.53% |
Rathbones Investment Management Ltd.as of 30 Jun 2024 | 195.92k | 0.29% |
Renaissance Technologies LLCas of 30 Jun 2024 | 171.80k | 0.26% |